Although we show that BRCA2 p.(Glu2599Gly) is hypomorphic in terms of DNA repair function, this study cannot provide a quantification of its estimated reduced cancer penetrance, due to the fact that it is presented together with another clearly deleterious variant and the lack of a significant number of patients harboring this missense variant. The gene discussed is BRCA2; the disease is cancer.